aluminum sulfate has been researched along with transforming growth factor beta in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (50.00) | 29.6817 |
| 2010's | 2 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Blessing, M; Finotto, S; Galle, PR; Herz, U; Köhler, H; Lohse, AW; Podlech, J; Protschka, M; Reddehase, MJ; Schramm, C | 1 |
| Edwards, L; Hussell, T; Lloyd, CM; Mathie, S; Openshaw, PJ; Schwarze, J; Tourdot, S; Wang, H | 1 |
| Akerman, L; Axelsson, S; Casas, R; Hjorth, M; Ludvigsson, J | 1 |
| Axelsson, S; Casas, R; Faresjö, M; Hjorth, M; Ludvigsson, J; Rydén, A | 1 |
1 trial(s) available for aluminum sulfate and transforming growth factor beta
| Article | Year |
|---|---|
GAD-alum treatment induces GAD65-specific CD4+CD25highFOXP3+ cells in type 1 diabetic patients.
Topics: Adolescent; Alum Compounds; Autoantibodies; CD4-Positive T-Lymphocytes; Cell Count; Child; Diabetes Mellitus, Type 1; Female; Forkhead Transcription Factors; Gene Expression; Glutamate Decarboxylase; Humans; Immunosuppression Therapy; Interferon-gamma; Interleukin-2 Receptor alpha Subunit; Interleukins; Leukocytes, Mononuclear; Lymphocyte Activation; Male; T-Lymphocytes, Regulatory; Th2 Cells; Transforming Growth Factor beta; Treatment Outcome; Tumor Necrosis Factor-alpha | 2011 |
3 other study(ies) available for aluminum sulfate and transforming growth factor beta
| Article | Year |
|---|---|
TGF-beta regulates airway responses via T cells.
Topics: Administration, Inhalation; Aerosols; Alum Compounds; Animals; Antibody Specificity; Bronchial Hyperreactivity; Bronchoalveolar Lavage Fluid; CD2 Antigens; Cell Movement; Epitopes, T-Lymphocyte; Humans; Immunoglobulin E; Immunohistochemistry; Inflammation; Interferon-gamma; Interleukin-13; Lung; Mice; Mice, Inbred Strains; Mice, Transgenic; Nitric Oxide Synthase; Nitric Oxide Synthase Type II; Ovalbumin; Protein Serine-Threonine Kinases; Receptor, Transforming Growth Factor-beta Type II; Receptors, Transforming Growth Factor beta; T-Lymphocyte Subsets; Th1 Cells; Transforming Growth Factor beta | 2003 |
Respiratory syncytial virus infection provokes airway remodelling in allergen-exposed mice in absence of prior allergen sensitization.
Topics: Alum Compounds; Analysis of Variance; Animals; Asthma; Bronchoalveolar Lavage Fluid; Collagen; Cytokines; Extracellular Matrix; Female; Fibroblast Growth Factor 2; Immunohistochemistry; Lung; Mice; Mice, Inbred BALB C; Ovalbumin; Respiratory Syncytial Virus Infections; Respiratory Syncytial Viruses; Statistics, Nonparametric; Transforming Growth Factor beta | 2008 |
Early induction of GAD(65)-reactive Th2 response in type 1 diabetic children treated with alum-formulated GAD(65).
Topics: Adolescent; Alum Compounds; Autoantibodies; Child; Diabetes Mellitus, Type 1; Follow-Up Studies; Forkhead Transcription Factors; Glutamate Decarboxylase; Humans; Immunologic Factors; Insulin; Interferon-gamma; Interleukins; Monocytes; Multicenter Studies as Topic; Protein Tyrosine Phosphatases; Randomized Controlled Trials as Topic; Th2 Cells; Transforming Growth Factor beta; Tumor Necrosis Factor-alpha | 2010 |